Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. UPLOAD Other SEC-generated Letter
  2. D Other Notice of Sales of Unregistered Securities
  3. S-3 Offering Registration Statement
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Material agreement · Unregistered share sale · Other events
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 34,148 shares (to pay taxes)
  7. 4 Grant or award Director acquired 37,735 shares (grant or award)
  8. 4 Grant or award Director acquired 37,735 shares (grant or award)
  9. 4 Grant or award Director acquired 37,735 shares (grant or award)
  10. 4 Grant or award Director acquired 37,735 shares (grant or award)
  11. 4 Grant or award Director acquired 37,735 shares (grant or award)
  12. 4 Grant or award Director acquired 37,735 shares (grant or award)
  13. 4 Grant or award Director acquired 37,735 shares (grant or award)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 21,347 shares (to pay taxes)
  15. 8-K Event Regulation FD disclosure
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Executive or director change
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
  20. 4 Grant or award Director acquired 79,470 shares (grant or award)

Page 13 of 80 · 1,583 filings